| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
103,439 |
92,304 |
$7.48M |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
35,450 |
33,016 |
$3.51M |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
48,467 |
45,214 |
$3.17M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
47,916 |
43,231 |
$2.54M |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
80,346 |
72,767 |
$2.10M |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
65,335 |
34,237 |
$871K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
43,446 |
40,233 |
$522K |
| 99215 |
Prolong outpt/office vis |
1,538 |
1,425 |
$151K |
| 87428 |
|
2,844 |
2,610 |
$106K |
| 87430 |
|
6,087 |
5,697 |
$76K |
| 99205 |
Prolong outpt/office vis |
541 |
480 |
$64K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
1,190 |
1,118 |
$54K |
| S9088 |
Services provided in an urgent care center (list in addition to code for service) |
19,787 |
17,469 |
$52K |
| 87400 |
|
11,201 |
5,531 |
$52K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
3,524 |
2,956 |
$40K |
| 71046 |
Radiologic examination, chest; 2 views |
1,791 |
1,621 |
$38K |
| 81025 |
|
5,197 |
4,814 |
$33K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
877 |
844 |
$29K |
| 81003 |
|
13,593 |
12,338 |
$23K |
| 87807 |
|
1,392 |
1,304 |
$17K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
338 |
301 |
$12K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
176 |
158 |
$9K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
705 |
619 |
$8K |
| 73610 |
|
329 |
315 |
$8K |
| 73630 |
|
315 |
289 |
$7K |
| 87420 |
|
669 |
636 |
$6K |
| S9083 |
Global fee urgent care centers |
218 |
199 |
$5K |
| 93000 |
|
356 |
332 |
$4K |
| 99051 |
|
22,739 |
20,778 |
$4K |
| 73130 |
|
118 |
105 |
$3K |
| 73140 |
|
110 |
101 |
$3K |
| E0114 |
Crutches underarm, other than wood, adjustable or fixed, pair, with pads, tips and handgrips |
47 |
45 |
$2K |
| 3074F |
|
635 |
617 |
$1K |
| 99000 |
|
1,892 |
1,757 |
$1K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
895 |
757 |
$908.28 |
| 3078F |
|
337 |
328 |
$850.00 |
| 73562 |
|
27 |
25 |
$767.78 |
| 69209 |
|
58 |
55 |
$644.41 |
| 73110 |
|
29 |
24 |
$553.73 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
640 |
551 |
$459.64 |
| 3079F |
|
232 |
226 |
$450.00 |
| 82962 |
|
192 |
177 |
$415.94 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
68 |
62 |
$361.26 |
| 86580 |
|
46 |
46 |
$343.08 |
| 73030 |
|
13 |
12 |
$300.58 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
321 |
282 |
$269.33 |
| 80047 |
|
29 |
27 |
$255.40 |
| 74018 |
|
13 |
12 |
$252.37 |
| 90688 |
|
16 |
16 |
$209.94 |
| 99386 |
|
116 |
111 |
$202.30 |
| A6449 |
Light compression bandage, elastic, knitted/woven, width greater than or equal to three inches and less than five inches, per yard |
116 |
110 |
$171.62 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
15 |
14 |
$152.00 |
| 3075F |
|
48 |
47 |
$100.00 |
| 3080F |
|
39 |
35 |
$100.00 |
| 86769 |
|
31 |
29 |
$94.13 |
| 3077F |
|
45 |
41 |
$75.00 |
| 85014 |
|
29 |
27 |
$68.61 |
| 36415 |
Collection of venous blood by venipuncture |
28 |
26 |
$57.09 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
84 |
67 |
$54.29 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
378 |
324 |
$13.58 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
41 |
38 |
$2.77 |
| A9150 |
Non-prescription drugs |
118 |
114 |
$0.00 |
| 1125F |
|
180 |
176 |
$0.00 |
| 1159F |
|
989 |
958 |
$0.00 |
| S0119 |
Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) |
106 |
97 |
$0.00 |